Zdrowie i gospodarka · 11/08/2016

FDA Extends Comment Period for Draft Guidance on Next-Generation Sequencing Diagnostic Devices

The US Food and Drug Administration (FDA) is extending the comment period for a draft guidance document on infectious disease diagnostic devices, allowing industry and FDA staff more time to review and provide feedback on the recommendations.